Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xencor Inc (NASDAQ:XNCR)

23.39
Delayed Data
As of Jul 27
 -0.68 / -2.83%
Today’s Change
18.22
Today|||52-Week Range
29.38
-11.13%
Year-to-Date
No recent news for Xencor Inc.

Today’s Trading

Previous close24.07
Today’s open24.19
Day’s range23.25 - 24.44
Volume139,417
Average volume (3 months)232,637
Market cap$1.1B
Dividend yield--
Data as of 07/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-321.43%
Earnings growth (next 5 years)--
Revenue growth (last year)+215.25%
P/E ratio57.0
Price/Sales12.75
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc-0.48-8.14%
AIMTAimmune Therapeutics...-0.50-2.28%
FWPForward Pharma A/S+0.09+0.42%
ESPREsperion Therapeutic...-2.79-5.62%
Data as of 07/27/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$87.5M
Annual profit (last year)$23.6M
Net profit margin26.99%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Secretary &
Vice President-Finance
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts